The first sign of inconsistency has to do with the theoretical molecular weight of the EIN2 C-terminus from S^645^ to the stop codon which is approximately 70 kDa. A 70 kDa fragment could migrate to the nucleus if cleavage occurred at S^645^, but the Qiao et al. immunoblots (see Fig. 3A and B in ref.[@R3]) showed an \~80 kDa EIN2 C-terminus peptide. The EIN2 C-terminus-YFP fusion peptide (Fig. 4G and H in ref. [@R3]) was also larger than expected from an S^645^ cleavage site. Although protein sizes can be difficult to estimate by SDS-PAGE, a cleavage site upstream of S^645^ could reasonably explain the \~10 kDa size excess. Wen et al. also revealed a product larger than predicted by cleavage at S^645^ and several smaller fragments. Hence, the immunoblots do not appear to be consistent with a single cleavage position at S^645^.

Qiao et al. reasoned that S^645^ is the cleavage site because EIN2 is differentially phosphorylated at S^645^ as originally shown by Chen et al. Subsequently, Qiao et al. used pseudo-multiple reaction monitoring (pMRM) mass spectrometry to detect changes in abundance between EIN2 tryptic peptides and their phosphorylated analogs before and after ET treatment. According to the Qiao et al. model (rendered in [Fig.  1](#F1){ref-type="fig"}), if EIN2 is cleaved at S^645^ after ET treatment, then the C-terminus moves from the ER to the nucleus. This means that the abundance of peptides downstream of S^645^ should decrease in ER membrane fractions after ET treatment and concomitantly increase in the nucleus. Immunoblots showing a preponderance of EIN2 antigen in nuclear preparations after ET treatment were consistent with the model (Fig. 3B in ref.[@R3]; Fig. 3K in ref. [@R4]), but the abundances of downstream peptides measured by pMRM were inconsistent (Table S1A in ref. [@R3]): Assuming that pMRM precisely measured a 10-fold change for phosphopeptide a.a. 648--662 in ER membranes, then the data unexpectedly showed no decrease in abundance of the analogous nonphosphorylated peptide a.a. 648--662 after ET treatment.

![**Figure 1.** EIN2 phosphorylation and cleavage products based on Qiao et al.[@R3](**A**) EIN2 in absence of ET (ambient air exposure) and digested with trypsin. EIN2 is phosphorylated (circled p) and remains anchored at the ER. (**B**) EIN2 in the presence of ET. EIN2 is not phosphorylated and is cleaved in vivo at S^645^ and the EIN2 C-terminus translocates to the nucleus (prior to trypsin digestion). The bottom bar shows the approximate molecular weight of native EIN2 as measured from the C-terminus. The author contends that the ET-induced cleavage site in model in B is not sufficiently proven by published results.](psb-8-e24721-g1){#F1}

Interestingly, Qiao et al. observed a 19-fold decrease for nonphosphorylated peptide a.a. 630--647 after ET treatment, but they attributed this to cleavage at S^645^ even though upstream cleavage would also explain the observation. It may be unintuitive why Qiao et al. reached that conclusion, so [Figure 1](#F1){ref-type="fig"} is provided for clarity. The amino acids K^629^ and R^647^ are trypsin digestion sites that flank S^645^ and after ET treatment and tryptic digestion the semi-tryptic peptide a.a. 630--645 should become more prevalent with increasing amounts of nonphosphorylated EIN2. Thus, Qiao et al. concluded that tryptic peptide a.a. 630--647 decreased because of prior, ET-mediated proteolytic cleavage at S^645^. Thus, they expected this would lead to an increased semi-tryptic variant after ET treatment and trypsin digestion and they found evidence of this by pMRM, which they cited as proof of cleavage at S^645^. Since the model dictates that the semi-tryptic peptide is prevalent after ET treatment, I re-examined the mass spectrometry data from Chen et al. which were sufficient to reveal differential phosphorylation of EIN2 at S^645^.[@R6] Mascot searches for semi-tryptic termini and error-tolerant searches for hundreds of mass deviations reconfirmed the phosphorylated tryptic peptide a.a. 630--647 in ambient air control seedlings and the nonphosphorylated form in ET-treated seedlings ([Table 1](#T1){ref-type="table"}). There was, however, no other prevalent mass modification in EIN2 peptides and the semi-tryptic peptide a.a. 630--645 was not apparent ([Table 1](#T1){ref-type="table"}). Of course, not finding a peptide by shotgun mass spectrometry rarely invalidates its existence,[@R7] but it is suspect that an essential nonphosphorylated semi-tryptic peptide predicted by Qiao et al. was more difficult to observe than its inherently-difficult-to-detect phosphorylated precursor. Thus, it can be argued that the available pMRM and shotgun proteomics data do not conclusively support EIN2 cleavage at S^645^.

###### Peptide-tandem mass spectrum matches from air (control) and ET-treated *A. thaliana* etiolated seedlings

  Air treated (control)                                                                                
  ----------------------- ------ ------ ----------- ----------- ----------- -------- ---- ------------ ----------------------------------------------------------
  329                     502    506    603.345     602.3378    602.3388    −1.67    25   0.063        D.ESIVR.L
  1221474                 511    539    1104.5542   3310.6408   3309.6286   306      51   0.00039      R.VKDQLDTTSVTSSVYDLPENILMTDQEIR.S
  1221420                 511    539    1104.2208   3309.6406   3309.6286   3.63     41   0.0035       R.VKDQLDTTSVTSSVYDLPENILMTDQEIR.S
  1221418                 511    539    1104.2197   3309.6374   3309.6286   2.64     36   0.0091       R.VKDQLDTTSVTSSVYDLPENILMTDQEIR.S
  811749                  552    567    886.933     1771.8515   1771.8476   2.23     44   0.00092      K.YSTSQVSSLKEDSDVK.E
  812432                  552    567    887.4352    1772.8558   1771.8476   569      45   0.00098      K.YSTSQVSSLKEDSDVK.E
  811742                  552    567    886.9304    1771.8463   1771.8476   −0.73    34   0.006        K.YSTSQVSSLKEDSDVK.E
  812434                  552    567    887.4361    1772.8576   1771.8476   570      33   0.0073       K.YSTSQVSSLKEDSDVK.E
  812425                  552    567    887.4332    1772.8519   1771.8476   567      25   0.091        K.YSTSQVSSLKEDSDVK.E
  878122                  630    647    944.4185    1886.8224   1886.82     1.24     92   0.00000033   K.AAPTSNFTVGSDGPPSFR.S + Phospho S (S)
  878123                  630    647    944.4192    1886.8238   1886.82     2.01     78   0.0000028    K.AAPTSNFTVGSDGPPSFR.S + Phospho S (S)
  878470                  630    647    944.9172    1887.8199   1886.82     530      64   0.000017     K.AAPTSNFTVGSDGPPSFR.S + Phospho S (S)
  878121                  630    647    944.4182    1886.8219   1886.82     0.98     56   0.000034     K.AAPTSNFTVGSDGPPSFR.S + Phospho S (S)
  878126                  630    647    944.4207    1886.8269   1886.82     3.63     62   0.00005      K.AAPTSNFTVGSDGPPSFR.S + Phospho S (S)
  878117                  630    647    944.4091    1886.8036   1886.82     −8.72    58   0.000087     K.AAPTSNFTVGSDGPPSFR.S + Phospho S (S)
  878472                  630    647    630.2815    1887.8227   1886.82     531      26   0.096        K.AAPTSNFTVGSDGPPSFR.S + Phospho S (S)
  936929                  648    666    668.6009    2002.7807   2001.7847   498      33   0.06         R.SLSGEGGSGTGSLSRLQGL.G + 2 Phospho S (S); Phospho T (T)
  423230                  700    710    646.8458    1291.6771   1291.6772   −0.094   44   0.0026       K.KLDQLFGTDQK.S
  423193                  700    710    646.8409    1291.6673   1291.6772   −7.65    30   0.075        K.KLDQLFGTDQK.S
  542771                  754    766    703.8643    1405.714    1405.7201   −4.39    69   0.000033     R.TPGSIDSLYGLQR.G
  542775                  754    766    703.8674    1405.7203   1405.7201   0.12     59   0.000064     R.TPGSIDSLYGLQR.G
  542786                  754    766    703.8703    1405.726    1405.7201   4.2      50   0.00038      R.TPGSIDSLYGLQR.G
  542779                  754    766    703.8681    1405.7217   1405.7201   1.13     44   0.0011       R.TPGSIDSLYGLQR.G
  608871                  754    766    743.8513    1485.6881   1485.6865   1.09     31   0.04         R.TPGSIDSLYGLQR.G + Phospho S (S)
  608879                  754    766    743.8526    1485.6907   1485.6865   2.87     35   0.068        R.TPGSIDSLYGLQR.G + Phospho S (S)
  274965                  835    843    551.3035    1100.5925   1100.5938   −1.16    45   0.0099       K.ERLEALQSR.G
  754564                  922    936    841.355     1680.6954   1680.6888   3.91     31   0.0072       K.YSSMPDISGLSMSAR.N + Phospho S (S)
  52751                   1211   1217   699.45      698.4427    698.4439    −1.65    20   0.062        A.AKPAKGK.C
  790762                  1269   1284   868.8923    1735.77     1735.7713   −0.74    31   0.062        R.LSNKPVGMNQDGPGSR.K + Phospho S (S)

  Ethylene treated                                                                             
  ------------------ ------ ------ ----------- ----------- ----------- ------- ---- ---------- -----------------------------------
  902435             511    539    1104.2163   3309.6271   3309.6286   −0.46   44   0.0012     R.VKDQLDTTSVTSSVYDLPENILMTDQEIR.S
  902516             511    539    1104.5494   3310.6265   3309.6286   302     34   0.016      R.VKDQLDTTSVTSSVYDLPENILMTDQEIR.S
  902436             511    539    1104.2182   3309.6327   3309.6286   1.24    29   0.056      R.VKDQLDTTSVTSSVYDLPENILMTDQEIR.S
  902520             511    539    1104.5546   3310.6419   3309.6286   306     31   0.087      R.VKDQLDTTSVTSSVYDLPENILMTDQEIR.S
  518666             552    567    591.6218    1771.8437   1771.8476   −2.22   26   0.06       K.YSTSQVSSLKEDSDVK.E
  536908             630    647    904.4321    1806.8497   1806.8537   −2.2    55   0.00013    K.AAPTSNFTVGSDGPPSFR.S
  241596             700    710    646.8446    1291.6747   1291.6772   −1.98   59   0.00026    K.KLDQLFGTDQK.S
  242470             700    710    647.3521    1292.6897   1291.6772   784     35   0.013      K.KLDQLFGTDQK.S
  241600             700    710    646.8446    1291.6747   1291.6772   −1.93   32   0.04       K.KLDQLFGTDQK.S
  778132             805    826    819.3732    2455.0977   2454.1022   406     65   0.000017   R.APSSSEGWEHQQPATVHGYQMK.S
  778133             805    826    819.3735    2455.0987   2454.1022   406     71   0.000056   R.APSSSEGWEHQQPATVHGYQMK.S
  777982             805    826    819.0399    2454.0977   2454.1022   −1.84   39   0.0054     R.APSSSEGWEHQQPATVHGYQMK.S
  142268             835    843    551.3033    1100.592    1100.5938   −1.61   37   0.065      K.ERLEALQSR.G
  309469             839    850    698.3436    1394.6727   1393.6715   718     23   0.096      E.ALQSRGEIPTSR.S + Phospho S (S)
  461623             1269   1284   828.9051    1655.7956   1655.8049   −5.63   58   0.000044   R.LSNKPVGMNQDGPGSR.K
  461625             1269   1284   828.9077    1655.8009   1655.8049   −2.46   38   0.0029     R.LSNKPVGMNQDGPGSR.K
  461621             1269   1284   828.9038    1655.7931   1655.8049   −7.18   37   0.0054     R.LSNKPVGMNQDGPGSR.K
  461619             1269   1284   552.9373    1655.7901   1655.8049   −8.95   31   0.051      R.LSNKPVGMNQDGPGSR.K

Spectra from Chen et al.[@R6] were searched as described in Chen et a.l,[@R6] but for semi-tryptic termini. Only the peptide-spectrum matches with expect values \< 0.1 are considered.

Qiao et al. and Ju et al. genetically assessed EIN2 phosphosites and showed that these are crucial for regulating EIN2 nuclear translocation, but these experiments may not have provided conclusive insight on positions of cleavage. For example, Qiao et al. substituted S^645^ with alanine (S^645^A), expressed EIN2^S645A^-YFP in transgenic plants, observed the translocation of YFP to the nucleus, and found an ET phenotype in the absence of ET treatment. Their results implied that the loss of phosphorylation is a regulatory signal that sends EIN2 to the nucleus. But while the S^645^A mutation will indeed inhibit phosphorylation at that position, it seems plausible that the mutation could also change the recognition site for the unknown protease that Qiao et al. concluded catalyzed hydrolysis there. Qiao et al. did not test by pMRM for the abundance of peptides with S^645^A termini, so it remains unknown whether the existence of such peptides were adversely affected. Notwithstanding, it is reasonable to suspect that the S^645^A mutation may have not inhibited potential upstream cleavage positions (evidenced by the larger-than-predicted size of the EIN2 fragment in Fig. 4G in ref. [@R3]). Thus, these genetic experiments supported a functional role of phosphorylation, but did not validate cleavage at S^645^.

In fact, there are other sites of phosphorylation on EIN2 shown by Chen et al. and Ju et al. that were not fully investigated by Qiao et al. Independent mutations on two different CTR1-regulated phosphosites revealed that ambient-air grown *A. thaliana* seedlings transgenic for EIN2^S645A^ expressed by the native *EIN2* promoter exhibited little ET-response phenotype, whereas EIN2^S942A^ transgenic seedlings exhibited a much stronger phenotype. Since the S^645^ site retained the potential to be phosphorylated in the EIN2^S924A^ seedlings in ambient air, it is likely that specific cleavage was blocked at S^645^ under the Qiao et al. model. But because EIN2^S924A^ produced a strong phenotype whereas EIN2^S645A^ did not, cleavage likely occurred elsewhere.

So what explains the strong phenotype for S^645^A observed by Qiao et al. when the same mutation conferred a weak phenotype for Ju et al.? Transgenic expression and protein accumulation may be the difference. Ju et al. revealed that transgenic seedlings overexpressing wild-type EIN2 from the constitutive CaMV *35S* promoter exhibited an unexpected, abnormal, strong ET-response phenotype in ambient air. Consequently, Ju et al. switched to using the native *EIN2* promoter. When they did, their EIN2 transgenics more closely resembled nontransgenic wild-type plants. Hence, expression and accumulation differences also likely explain why Ju et al. observed a slight ET phenotype for EIN2^S645A^ transgenic seedlings with the native *EIN2* promoter but a stronger ET phenotype for the EIN2^S645A^ transgenic seedlings with a *35S* promoter. Therefore, it is possible that the same strong phenotype for the same S^645^A mutation observed by Qiao et al. may have been due to their use of the *35S* promoter as well. In that case, excessive and constant accumulation of EIN2^S645A^ may have short-circuited CTR1 control, preventing phosphorylation at the unexamined S^924^ site (mimicking S^924^A in Ju et al.) and leading to an inadvertent but stronger phenotype that masked the weaker effect of S^645^A.

The results from four papers reveal that differential phosphorylation of EIN2 controls EIN2-mediated activation of transcription at the nucleus and leads to ET-regulated proteomic changes.[@R3]^-^[@R6] Nevertheless, on the basis of the conflicting evidence, specific cleavage at S^645^ is controversial.
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